Abstract: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk for several adverse outcomes among patients with diabetic kidney disease. Yet, optimal timing for …
Abstract: BACKGROUND: The effect of SGLT2i on kidney function after acute kidney injury (AKI) is unknown. METHODS: The study population was drawn from a retrospective cohort of …
Abstract: BACKGROUND: Mortality is high within the first few months of starting chronic dialysis. Pre-ESKD trajectory of kidney function has been shown to be predictive of early …